Experience

Nuage Therapeutics

• Spain
• Biotechnology Research
• 1 - 100 Employee

• Co-Founder, CEO & Board Member

  • Apr 2022 - Present

  Nuage Therapeutics is a spin-off from the IRB Barcelona and ICREA, founded by the researchers renowned researchers in the field of biomolecular condensates and intrinsically disordered proteins Xavier Salvatella, Mateusz Biesaga and Denes Hnisz. Based at the Barcelona Science Park, Nuage Therapeutics has a proprietary screening assay for the discovery of drugs targeting intrinsically disordered proteins that undergo biomolecular condensation, thus providing new treatments for… Show more Nuage Therapeutics is a spin-off from the IRB Barcelona and ICREA, founded by the researchers renowned researchers in the field of biomolecular condensates and intrinsically disordered proteins Xavier Salvatella, Mateusz Biesaga and Denes Hnisz. Based at the Barcelona Science Park, Nuage Therapeutics has a proprietary screening assay for the discovery of drugs targeting intrinsically disordered proteins that undergo biomolecular condensation, thus providing new treatments for undruggable proteins involved in diseases with unmet medical needs. Show less



Advent France Biotechnology (now AdBio Partners)

• Member of the Scientific and Business Advisory Committee

  • Sep 2021 - Present

  Paris, France Advent France Biotechnology focuses on ground-breaking innovations in Life Sciences to address unmet medical and clinical needs, building the next generation of pioneering healthcare companies. Keeping in mind patients’ well-being, we believe in improving medical care and taking medical innovations further ahead.



CataloniaBio & HealthTech

• Spain
• Biotechnology Research
• 1 - 100 Employee

• Chief Executive Officer

  • Feb 2021 - Dec 2021

  Barcelona, Catalonia, Spain CataloniaBio is the association of companies in the health and life sciences arena in Catalonia. Its mission is to represent and support companies interested in promoting a strategic, innovative cluster, as well as helping to define the framework for sector-wide actions and industrial policies established at a national and European level.

• President

  • Mar 2020 - Jan 2021

• Board Member

  • Mar 2018 - Feb 2020

  Barcelona Area, Spain



Northern Biologics

• United States
• Veterinary

• VP Operations and Corporate Affairs

  • Jun 2017 - Jan 2021

  Toronto, Canada Area At Northern Biologics, we’re using state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis. As an innovative discovery stage therapeutic antibody company, we’ve brought together world-class scientists and institutions for powerful cross-collaboration. With an entrepreneurial mindset and backed by seasoned investors and partners, we’re advancing a promising pipeline of targeted therapeutics.



Mosaic Biomedicals

• Co-Founder & General Manager

  • Aug 2016 - Jan 2021

  Barcelona Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments specifically designed to target cancer stem cells. Mosaic’s innovative treatments are derived from a deep comprehension of the tumor biology and want to offer safer and more effective options to cancer patients. Awards: o "BioSuccess 2016" award granted by CataloniaBio (Catalan association of life sciences companies) to Mosaic for the most significant transaction of the year o "BioEmprenedor… Show more Mosaic Biomedicals is a Barcelona-based company that develops personalized cancer treatments specifically designed to target cancer stem cells. Mosaic’s innovative treatments are derived from a deep comprehension of the tumor biology and want to offer safer and more effective options to cancer patients. Awards: o "BioSuccess 2016" award granted by CataloniaBio (Catalan association of life sciences companies) to Mosaic for the most significant transaction of the year o "BioEmprenedor XXI" 2012 Program winner. Mosaic was recognized as the "Biosciences Start-up with the Greatest Growth Potential" voted by 25 experts from the biotech industry and venture capital. Organized by the "Chamber of Commerce", Barcelona Activa (Barcelona City Council), Genoma España, Biocat and Caixa Capital Risc o "Best Biotech Project in Spain 2012" award given by The Science and Technology Spanish Foundation (FECyT) o "Best Entrepreneurial Project in Biotechnology 2012" award sponsored by the Spanish Association of Biocompanies (ASEBIO), Genoma España, the Spanish Association of Biotechnology (SEBiot) and the Spanish Association of Biochemistry and Molecular Biology (SEBBM)

• Co-founder & CEO

  • Jun 2012 - Aug 2016

  Barcelona y alrededores, España



Biocat, BioRegion of Catalonia

• Spain
• Biotechnology Research
• 1 - 100 Employee

• Mentor at d·Health Barcelona (MOEBIO)- Accelerating Entrepreneurship and Innovation in Healthcare

  • Jun 2018 - Dec 2019

  Barcelona Area, Spain Design Health Barcelona (d·HEALTH Barcelona) is a postgraduate program to develop entrepreneurs and future leaders in healthcare innovation.



Vall d'Hebron Institute of Oncology

• Research Services
• 1 - 100 Employee

• Project Development. Laboratory of Gene Expression and Cancer

  • Jun 2012 - May 2014

  Barcelona y alrededores, España



Genentech (A member of the Roche Group)

• Associate, Pipeline and Portfolio Planning Team

  • May 2011 - Sep 2011

  San Francisco, CA (US) • Led a cross-functional global project to calculate the $400M+ added potential value of the E7 emerging markets for an oncology drug. Recommended country-specific prioritization of indications to optimize patient access. Cooperated with product managers, business analysts and medical advisors in the affiliate markets. • Partnered with ZS Associates to evaluate 10+ Hematological diseases leveraging scientific, clinical, commercial, and portfolio information. Provided strategic insights… Show more • Led a cross-functional global project to calculate the $400M+ added potential value of the E7 emerging markets for an oncology drug. Recommended country-specific prioritization of indications to optimize patient access. Cooperated with product managers, business analysts and medical advisors in the affiliate markets. • Partnered with ZS Associates to evaluate 10+ Hematological diseases leveraging scientific, clinical, commercial, and portfolio information. Provided strategic insights to prioritize and optimize the Hematology Franchise strategy and investments. Show less



Vall d'Hebron Institute of Oncology (VHIO)

• Research Services
• 1 - 100 Employee

• Postdoctoral Researcher. Laboratory of Gene Expression and Cancer.

  • Sep 2006 - Jul 2010

  Barcelona y alrededores, España Mentor: Prof. Joan Seoane, PhD



Rafael del Pino Alumni Association

• Executive Committee

  • 2007 - 2010

  Madrid y alrededores, España • Led Association activities in Barcelona: organized conferences, networking events and alumni meetings. • Proposed, raised funds, launched and coordinated the “Entrepreneurs Forums” (event held three times per year).

• Ph.D. Student. Growth Factors Laboratory.

  • Jul 2000 - Jul 2006

  Barcelona y alrededores, España Mentors: Prof. Josep Baselga, MD, PhD; Dr. Joaquin Arribas, PhD